Review: The Diagnostic Accuracy of Dementia-Screening Instruments With an Administration Time of 10 to 45 Minutes for Use in Secondary Care: A Systematic Review
Free accessReview articleFirst published online June, 2010
Review: The Diagnostic Accuracy of Dementia-Screening Instruments With an Administration Time of 10 to 45 Minutes for Use in Secondary Care: A Systematic Review
Early screening for dementia is crucial for identifying reversible causes as well as managing, counseling, and other therapeutic interventions. Many reviews have compared the suitability of very brief screening instruments for use in primary care, but reviews on more extensive instruments in secondary care are scarce. In addition, results on diagnostic accuracy are often biased due to methodological shortcomings, differences in the spectrum of patients or reporting. This systematic review reports the diagnostic accuracy of dementia-screening instruments with an administration time of 10 to 45 minutes, validated in secondary care, restricted to mild dementia and validation studies of ‘‘high quality.’’ Characteristics such as cognitive domains and reliability figures are also highlighted.
Boustani M., Peterson B., Hanson L., Harris R., Lohr KNScreening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003; 138(11):927-937.
2.
Ganguli M.The use of screening instruments for the detection of dementia. Neuroepidemiology. 1997;16(6):271-280.
3.
Lang MMScreening for cognitive impairment in the older adult. Nurse Pract.2001;26(11):26, 32-37, 41.
4.
Ouldred E.Screening for dementia in older people. Br J Community Nurs . 2004;9(10):434-437.
5.
Ritchie K.The screening of cognitive impairment in the elderly: a critical review of current methods. J Clin Epidemiol. 1988;41(7): 635-643.
6.
Sandson TA, Price BHDiagnostic testing and dementia. Neurol Clin. 1996;14(1):45-59.
7.
Patterson CJ , Gass DAScreening for cognitive impairment and dementia in the elderly. Can J Neurol Sci. 2001;28(suppl 1):S42-S51.
8.
Brodaty H., Low LF, Gibson L., Burns K.What is the best dementia screening instrument for general practitioners to use? Am J Geriatr Psychiatry. 2006;14(5):391-400.
9.
Grace J., Amick MMCognitive screening of older adults. Med Health R I. 2005;88(1):8-11.
10.
Harvan JR, Cotter V.An evaluation of dementia screening in the primary care setting. J Am Acad Nurse Pract. 2006;18(8):351-360.
11.
Ismail Z., Rajji TK, Shulman KIBrief cognitive screening instruments: an update. Int J Geriatr Psychiatry.2010;25(2):111-120.
12.
Lorentz WJ, Scanlan JM, Borson S.Brief screening tests for dementia. Can J Psychiatry. 2002;47(8):723-733.
13.
Milne A., Culverwell A., Guss R., Tuppen J., Whelton R.Screening for dementia in primary care: a review of the use, efficacy and quality of measures. Int Psychogeriatr. 2008 ;20(5):911-926.
14.
White H., Davis PBCognitive screening tests: an aid in the care of elderly outpatients. J Gen Intern Med. 1990;5(5):438-445.
15.
Woodford HJ , George J.Cognitive assessment in the elderly: a review of clinical methods. QJM. 2007;100(8):469-484.
16.
Nunnally J., Bernstein I.Psychometric Theory. 3rd ed. New York, NY: McGraw-Hill; 1994.
17.
Huppert FA, Brayne C., Gill C., Paykel ES, Beardsall L.CAM-COG-a concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample. Br J Clin Psychol.1995;34(pt4):529-541.
18.
Teng EL, Hasegawa K., Homma A., et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr. 1994;6(1):45-58.
Reid MC, Lachs MS, Feinstein ARUse of methodological standards in diagnostic test research. Getting better but still not good. JAMA. 1995;274(8):645-651.
21.
Brayne C., Day N., Gill C.Methodological issues in screening for dementia. Neuroepidemiology . 1992;11(suppl 1):88-93.
22.
Cook C., Cleland J., Huijbregts P.Creation and critique of studies of diagnostic accuracy: use of the STARD and QUADAS methodological quality assessment tools. J Man Manip Ther. 2007;15(2):93-102.
23.
Deeks JJSystematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ. 2001;323(7305):157-162.
24.
Gifford DR, Cummings JLEvaluating dementia screening tests: methodologic standards to rate their performance. Neurology. 1999;52(2):224-227.
25.
Siu ALScreening for dementia and investigating its causes. Ann Intern Med. 1991;115(2):122-132.
26.
Whiting P., Rutjes AW, Dinnes J., Reitsma J., Bossuyt PM, Kleijnen J.Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess. 2004 ;8(25):1-234.
27.
Lijmer JG, Mol BW, Heisterkamp S., et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA. 1999;282(11):1061-1066.
28.
Westwood ME , Whiting PF, Kleijnen J.How does study quality affect the results of a diagnostic meta-analysis? BMC Med Res Methodol. 2005;5(1):20.
29.
First MB, Frances AJ, Pincus HAHandbook of Differential Diagnosis. Diagnostic and Statistical Manual of Mental Disorders-IV-TR. 2002.
30.
Whiting P., Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J.The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.
31.
Whiting PF, Westwood ME, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J.Evaluation of QUADAS: a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol. 2006;6:9.
32.
Zanetti O., Frisoni GB, Rozzini L., Bianchetti A., Trabucchi M.Validity of direct assessment of functional status as a tool for measuring Alzheimer’s disease severity. Age Ageing. 1998;27(5):615-622.
33.
McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan EMClinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34(7):939-944.
34.
Larson DB, Lyons JS, Bareta JC, Burns BJ, Blazer DG, Goldstrom IDThe construct validity of the ischemic score of Hachinski for the detection of dementias. J Neuropsychiatry Clin Neurosci. 1989;1(2):181-187.
35.
Roman GC, Tatemichi TK, Erkinjuntti T., et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology . 1993;43(2):250-260.
36.
McKeith IG, Galasko D., Kosaka K., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47(5):1113-1124.
37.
Neary D., Snowden JS, Gustafson L., et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546-1554.
38.
Greenhalgh T.How to read a paper. Papers that report diagnostic or screening tests. BMJ. 1997;315(7107):540-543.
39.
Jaeschke R. , Guyatt GH, Sackett DLUsers’ guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA. 1994;271(9):703-707.
40.
Lezak MD, Howieson DB, Loring WLNeuropsychological Assessment. 4th ed. New York, NY: Oxford University Press; 2004.
41.
Chu LW, Chiu KC, Hui SL, Yu GK, Tsui WJ, Lee PWThe reliability and validity of the Alzheimer’s Disease Assessment Scale Cognitive Subscale (ADAS-Cog) among the elderly Chinese in Hong Kong. Ann Acad Med Singapore. 2000;29(4):474-485.
42.
Hannesdottir K., Snaedal J.A study of the Alzheimer’s Disease Assessment Scale-Cognitive (ADAS-Cog) in an Icelandic elderly population. Nord J Psychiatry. 2002;56(3):201-206.
43.
Liu HC, Teng EL, Chuang YY, Lin KN, Fuh JL, Wang PNThe Alzheimer’s Disease Assessment Scale: findings from a low-education population. Dement Geriatr Cogn Disord. 2002 ;13(1):21-26.
44.
Mavioglu H. , Gedizlioglu M., Akyel S., Aslaner T., Eser E.The validity and reliability of the Turkish version of Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer’s disease and normal subjects . Int J Geriatr Psychiatry. 2006;21(3):259-265.
45.
Schultz RR, Siviero MO, Bertolucci PHThe cognitive subscale of the ‘‘Alzheimer’s Disease Assessment Scale’’ in a Brazilian sample. Braz J Med Biol Res. 2001;34(10):1295-1302.
46.
Tsolaki M., Fountoulakis K., Nakopoulou E., Kazis A., Mohs RCAlzheimer’s Disease Assessment Scale: the validation of the scale in Greece in elderly demented patients and normal subjects. Dement Geriatr Cogn Disord. 1997;8(5):273-280.
47.
Zec RF, Landreth ES, Vicari SK, et al. Alzheimer disease assessment scale: useful for both early detection and staging of dementia of the Alzheimer type. Alzheimer Dis Assoc Disord. 1992;6(2):89-102.
48.
Alexopoulos P., Greim B., Nadler K., et al. Validation of the Addenbrooke’s cognitive examination for detecting early Alzheimer’s disease and mild vascular dementia in a German population. Dement Geriatr Cogn Disord. 2006;22(5-6):385-391.
Bier JC, Ventura M., Donckels V., et al. Is the Addenbrooke’s cognitive examination effective to detect frontotemporal dementia? J Neurol. 2004;251(4):428-431.
51.
Bier JC, Donckels V., Van Eyll E., et al. The French Addenbrooke’s cognitive examination is effective in detecting dementia in a French-speaking population. Dement Geriatr Cogn Disord. 2005;19(1):15-17.
52.
Dudas RB, Berrios GE, Hodges JRThe Addenbrooke’s cognitive examination (ACE) in the differential diagnosis of early dementias versus affective disorder. Am J Geriatr Psychiatry. 2005; 13(3):218-226.
53.
Garcia-Caballero A., Garcia-Lado I., Gonzalez-Hermida J., et al. Validation of the Spanish version of the Addenbrooke’s Cognitive Examination in a rural community in Spain. Int J Geriatr Psychiatry.2006;21(3):239-245.
54.
Larner AJAn audit of the Addenbrooke’s Cognitive Examination (ACE) in clinical practice. Int J Geriatr Psychiatry. 2005; 20(6):593-594.
55.
Larner AJAudit of the Addenbrooke’s Cognitive Examination (ACE) in clinical practice: 2. Longitudinal change. Int J Geriatr Psychiatry. 2006;21(7):698-699.
56.
Larner AJAddenbrooke’s Cognitive Examination-Revised (ACE-R) in day-to-day clinical practice. Age Ageing.2007;36(6):685-686.
57.
Larner AJAddenbrooke’s Cognitive Examination (ACE) for the diagnosis and differential diagnosis of dementia. Clin Neurol Neurosurg.2007;109(6):491-494.
58.
Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W., Hodges JRA brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology . 2000;55(11):1613-1620.
59.
Mioshi E., Dawson K., Mitchell J., Arnold R., Hodges JRThe Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry . 2006;21(11):1078-1085.
60.
Reyes MA, Lloret SP, Gerscovich ER, Martin ME, Leiguarda R., Merello M.Addenbrooke’s Cognitive Examination validation in Parkinson’s disease. Eur J Neurol.2009;16(1):142-147.
61.
Hopkins RW, Kilik LA, Day DJ, Rows CP, Hamilton PFThe brief Kingston Standardized Cognitive Assessment-revised. Int J Geriatr Psychiatry. 2005;20(3):227-231.
62.
Aprahamian I., Martinelli JE, Neri AL, Yassuda MSThe accuracy of the Clock Drawing Test compared to that of standard screening tests for Alzheimer’s disease: results from a study of Brazilian elderly with heterogeneous educational backgrounds . Int Psychogeriatr.2010;22(1):64-71.
63.
Heinik J., Solomesh I., Bleich A., Berkman P.Are the clock-drawing test and the MMSE combined interchangeable with CAMCOG as a dementia evaluation instrument in a specialized outpatient setting? J Geriatr Psychiatry Neurol. 2003;16(2):74-79.
64.
Heinik J., Solomesh I.Validity of the Cambridge Cognitive Examination-Revised new Executive Function Scores in the diagnosis of dementia: some early findings. J Geriatr Psychiatry Neurol. 2007;20(1):22-28.
65.
Hendrie HC, Hall KS, Brittain HM, et al. The CAMDEX: a standardized instrument for the diagnosis of mental disorder in the elderly: a replication with a US sample. J Am Geriatr Soc. 1988;36(5):402-408.
66.
Hobson P., Meara J.The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson’s disease by use of the CAMCOG neuropsychological test. Age Ageing. 1999;28(1):39-43.
67.
van Hout H., Teunisse S., Derix M., et al. CAMDEX, can it be more efficient? Observational study on the contribution of four screening measures to the diagnosis of dementia by a memory clinic team. Int J Geriatr Psychiatry. 2001;16(1):64-69.
68.
Lindeboom J., Ter Horst R., Hooyer C., Dinkgreve M., Jonker C.Some psychometric properties of the CAMCOG. Psychol Med. 1993;23(1):213-219.
69.
Nunes PV, Diniz BS, Radanovic M., et al. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education . Int J Geriatr Psychiatry. 2008;23(11):1127-1133.
70.
Tsolaki M., Fountoulakis KN, Chantzi H., Kazis A.The Cambridge Cognitive Examination (CAMCOG): a validation study in outpatients suffering from dementia and non-demented elderly subjects (including Age Associated Cognitive Decline patients) in Greece. Am J Alzheimers Dis Other Demen. 2000;15(5):269-276.
71.
Williams RN , McIntosh DE, Eells GT, Dean RS, Hendrie H.Neuropsychological subgroups of dementia of the Alzheimer’s type. Int J Neurosci. 1996;87(1-2):79-90.
72.
Lin KN, Wang PN, Liu CY, Chen WT, Lee YC, Liu HCCutoff scores of the cognitive abilities screening instrument, Chinese version in screening of dementia. Dement Geriatr Cogn Disord. 2002;14(4):176-182.
73.
Tsai RC, Lin KN, Wu KY, Liu HCImproving the screening power of the cognitive abilities screening instrument, Chinese version. Dement Geriatr Cogn Disord. 2004;18(3-4):314-320.
74.
Drachman DA , Swearer JM, Kane K., Osgood D., O’Toole C., Moonis M.The cognitive assessment screening test (CAST) for dementia. J Geriatr Psychiatry Neurol. 1996;9(4):200-208.
75.
Wolfe N., Imai Y., Otani C., et al. Criterion validity of the cross-cultural cognitive examination in Japan. J Gerontol. 1992;47(4):289-291.
76.
Glosser G., Wolfe N., Kliner-Krenzel L., Albert MLCross-Cultural Cognitive Examination performance in patients with Parkinson’s disease and Alzheimer’s disease. J Nerv Ment Dis. 1994; 182(8):432-436.
77.
Liu SI, Prince M., Chiu MJ, Chen TF, Sun YW, Yip PKValidity and reliability of a Taiwan Chinese version of the community screening instrument for dementia. Am J Geriatr Psychiatry. 2005;13(7):581-588.
78.
Arnold BR, Cuellar I., Guzman N.Statistical and clinical evaluation of the Mattis Dementia Rating Scale-Spanish adaptation: an initial investigation. J Gerontol B Psychol Sci Soc Sci. 1998;53(6):364-369.
79.
Chey J., Na DR, Park S., Park E., Lee S.Effects of education in dementia assessment: evidence from standardizing the Korean-Dementia Rating Scale. Clin Neuropsychol. 1999;13(3):293-302.
80.
Chan AS, Choi A., Chiu H., Lam L.Clinical validity of the Chinese version of Mattis Dementia Rating Scale in differentiating dementia of Alzheimer’s type in Hong Kong. J Int Neuropsychol Soc. 2003;9(1):45-55.
81.
Hofer SM, Piccinin AM, Hershey D.Analysis of structure and discriminative power of the Mattis Dementia Rating Scale. J Clin Psychol. 1996;52(4):395-409.
82.
Llebaria G. , Pagonabarraga J., Kulisevsky J., et al. Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson’s disease. Mov Disord. 2008;23(11):1546-1550.
83.
Lyness SA, Hernandez I., Chui HC, Teng ELPerformance of Spanish speakers on the Mattis dementia rating scale (MDRS) . Arch Clin Neuropsychol. 2006;21(8):827-836.
84.
Marcopulos BA, Gripshover DL, Broshek DK, McLain CA, Brashear HRNeuropsychological assessment of psychogeriatric patients with limited education. Clin Neuropsychol. 1999;13(2): 147-156.
85.
Mohr E., Walker D., Randolph C., Sampson M., Mendis T.Utility of clinical trial batteries in the measurement of Alzheimer’s and Huntington’s dementia. Int Psychogeriatr. 1996;8(3):397-411.
86.
Monsch AU, Bondi MW, Salmon DP, et al. Clinical validity of the Mattis Dementia Rating Scale in detecting Dementia of the Alzheimer type. A double cross-validation and application to a community-dwelling sample. Arch Neurol. 1995;52(9):899-904.
87.
Paolo AM, Troster AI, Glatt SL, Hubble JP, Koller WCInfluence of demographic variables on the Dementia Rating Scale. J Geriatr Psychiatry Neurol. 1995;8(1):38-41.
88.
Porto CS, Fichman HC, Caramelli P., Bahia VS, Nitrini R.Brazilian version of the Mattis dementia rating scale: diagnosis of mild dementia in Alzheimer’s disease. Arq Neuropsiquiatr. 2003;61(2B):339-345.
89.
van Gorp WG , Marcotte TD, Sultzer D., Hinkin C., Mahler M., Cummings JLScreening for dementia: comparison of three commonly used instruments. J Clin Exp Neuropsychol. 1999; 21(1):29-38.
90.
Vitaliano PP , Breen AR, Russo J., Albert M., Vitiello MV, Prinz PNThe clinical utility of the dementia rating scale for assessing Alzheimer patients. J Chronic Dis. 1984;37(9-10):743-753.
91.
Pfeffer RI, Kurosaki TT, Harrah CH Jr., et al. A survey diagnostic tool for senile dementia. Am J Epidemiol. 1981;114(4):515-527.
92.
Pfeffer RI, Kurosaki TT, Chance JM, Filos S., Bates D.Use of the mental function index in older adults. Reliability, validity, and measurement of change over time. Am J Epidemiol. 1984; 120(6):922-935.
93.
Lee JY, Dong WL, Cho SJ, et al. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment . J Geriatr Psychiatry Neurol. 2008;21(2):104-110.
94.
Nasreddine ZS, Phillips NA, Bedirian V., et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699.
95.
Smith T., Gildeh N., Holmes C.The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. Can J Psychiatry. 2007;52(5):329-332.
96.
Walterfang M., Siu R., Velakoulis D.The NUCOG: validity and reliability of a brief cognitive screening tool in neuropsychiatric patients. Aust N Z J Psychiatry. 2006;40(11-12):995-1002.
97.
Duff K., Humphreys Clark JD, O’Bryant SE, Mold JW, Schiffer RB, Sutker PBUtility of the RBANS in detecting cognitive impairment associated with Alzheimer’s disease: sensitivity, specificity, and positive and negative predictive powers . Arch Clin Neuropsychol.2008;23(5):603-612.
98.
Randolph C., Tierney MC, Mohr E., Chase TNThe Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol. 1998;20(3):310-319.
99.
Storey JE, Rowland JT, Basic D., Conforti DA, Dickson HGThe Rowland Universal Dementia Assessment Scale (RUDAS): a multicultural cognitive assessment scale. Int Psychogeriatr. 2004;16(1):13-31.
100.
Iype T., Ajitha BK, Antony P., Ajeeth NB, Job S., Shaji KSUsefulness of the Rowland Universal Dementia Assessment scale in South India . J Neurol Neurosurg Psychiatry. 2006; 77(4):513-514.
101.
Rowland JT , Basic D., Storey JE, Conforti DAThe Rowland Universal Dementia Assessment Scale (RUDAS) and the Folstein MMSE in a multicultural cohort of elderly persons . Int Psychogeriatr. 2006;18(1):111-120.
102.
Solomon PR , Hirschoff A., Kelly B., et al. A 7 minute neurocognitive screening battery highly sensitive to Alzheimer’s disease. Arch Neurol. 1998;55(3):349-355.
103.
Meulen EF, Schmand B., van Campen JP, et al. The seven minute screen: a neurocognitive screening test highly sensitive to various types of dementia. J Neurol Neurosurg Psychiatry. 2004; 75(5):700-705.
104.
Ijuin M., Homma A., Mimura M., et al. Validation of the 7-Minute Screen for the detection of early-stage Alzheimer’s disease. Dement Geriatr Cogn Disord. 2008;25(3):248-255.
105.
Skjerve A. , Nordhus IH, Engedal K., et al. Validation of the Seven Minute Screen and Syndrom Kurztest among elderly Norwegian outpatients. Int Psychogeriatr. 2008;20(4):807-814.
106.
Tsolaki M. , Iakovidou V., Papadopoulou E., et al. Greek validation of the seven-minute screening battery for Alzheimer’s disease in the elderly. Am J Alzheimers Dis Other Demen. 2002;17(3): 139-148.
107.
Heinik J., Werner P., Mendel A., Raikher B., Bleich A.The Cambridge Cognitive Examination (CAMCOG): validation of the Hebrew version in elderly demented patients. Int J Geriatr Psychiatry. 1999;14(12):1006-1013.
108.
Rosen WG, Mohs RC, Davis KLA new rating scale for Alzheimer’s disease. Am J Psychiatry . 1984;141(11):1356-1364.
109.
Pena-Casanova J.Alzheimer’s Disease Assessment Scale-cognitive in clinical practice. Int Psychogeriatr.1997 ;9(suppl 1):105-114.
110.
Weyer G., Erzigkeit H., Kanowski S., Ihl R., Hadler D.Alzheimer’s Disease Assessment Scale: reliability and validity in a multicenter clinical trial. Int Psychogeriatr.1997;9(2):123-138.
111.
Kim YS , Nibbelink DW, Overall JEFactor structure and reliability of the Alzheimer’s Disease Assessment Scale in a multicenter trial with linopirdine. J Geriatr Psychiatry Neurol. 1994;7(2):74-83.
Paradela EM , Lopes CS, Lourenco RAReliability of the Brazilian version of the Cambridge Cognitive Examination Revised CAMCOG-R. Arq Neuropsiquiatr.2009;67(2B):439-444.
114.
Roth M., Tym E., Mountjoy CQ, et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia . Br J Psychiatry. 1986;149(6):698-709.
115.
Lindeboom R., Schmand B., Holman R., de Haan RJ, Vermeulen M.Improved brief assessment of cognition in aging and dementia. Neurology. 2004;63(3):543-546.
Coblentz JM , Mattis S., Zingesser LH, Kasoff SS, Wisniewski HM, Katzman R.Presenile dementia. Clinical aspects and evaluation of cerebrospinal fluid dynamics. Arch Neurol. 1973;29(5):299-308.
118.
Gardner R. Jr., Oliver-Munoz S., Fisher L., Empting L.Mattis Dementia Rating Scale: internal reliability study using a diffusely impaired population . J Clin Neuropsychol. 1981;3(3):271-275.
119.
Smith GE, Ivnik RJ, Malec JF, Kokmen E., Tangalos E., Petersen RCPsychometric properties of the Mattis Dementia Rating Scale. Assessment. 1994;1(2):123-132.
120.
Wong A., Xiong YY, Kwan PW, et al. The validity, reliability and clinical utility of the Hong Kong Montreal Cognitive Assessment (HK-MoCA) in patients with cerebral small vessel disease. Dement Geriatr Cogn Disord.2009;28(1):81-87.
121.
Rahman TT, El Gaafary MMMontreal Cognitive AssessmentArabic version: reliability and validity prevalence of mild cognitive impairment among elderly attending geriatric clubs in Cairo . Geriatr Gerontol Int.2009;9(1):54-61.
122.
Gill DJ, Freshman A., Blender JA, Ravina B.The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson’s disease. Mov Disord. 2008;23(7):1043-1046.
123.
Duff K., Beglinger LJ, Schoenberg MR, et al. Test-retest stability and practice effects of the RBANS in a community dwelling elderly sample. J Clin Exp Neuropsychol . 2005; 27(5):565-575.
124.
Solomon PR , Brush M., Calvo V., et al. Identifying dementia in the primary care practice. Int Psychogeriatr. 2000;12(4):483-493.
125.
Verhey FR, Houx P., Van Lang N., et al. Cross-national comparison and validation of the Alzheimer’s Disease Assessment Scale: results from the European Harmonization Project for Instruments in Dementia (EURO-HARPID). Int J Geriatr Psychiatry . 2004;19(1):41-50.
126.
Kessels RP , Mimpen G., Melis R., Rikkert MGMeasuring impairments in memory and executive function in older people using the Revised Cambridge Cognitive Examination . Am J Geriatr Psychiatry.2009;17(9):793-801.
127.
Mattis S.Mental status examination for organic mental syndrome in the elderly patient . In: Bellak L, Karasu TB, eds. Geriatric Psychiatry: A Handbook for Psychiatrists and Primary Care Physicians. New York, NY: Grune & Stratton;1970:77-101.
Kiernan RJ, Mueller J., Langston JW, Van Dyke C.The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Ann Intern Med. 1987; 107(4):481-485.
130.
Fields SD, Fulop G., Sachs CJ, Strain J., Fillit H.Usefulness of the Neurobehavioral Cognitive Status Examination in the hospitalized elderly. Int Psychogeriatr. 1992;4(1):93-102.
131.
Duff K., Patton D., Schoenberg MR, Mold J., Scott JG, Adams RLAge- and education-corrected independent normative data for the RBANS in a community dwelling elderly sample. Clin Neuropsychol. 2003;17(3):351-366.
132.
Benton ALContributions to Neuropsychological Assessment: A Clinical Manual. New York, NY: Oxford University Press; 1983.
133.
Grober E., Buschke H., Crystal H., Bang S., Dresner R.Screening for dementia by memory testing. Neurology. 1988;38(6):900-903.
134.
Skjerve A. , Nordhus IH, Engedal K., Pallesen S., Braekhus A., Nygaard HASeven minute screen performance in a normal elderly sample. Int J Geriatr Psychiatry. 2007;22(8):764-769.
135.
Drane DL, Osato SSUsing the neurobehavioral cognitive status examination as a screening measure for older adults. Arch Clin Neuropsychol. 1997;12(2):139-143.
136.
Drane DL, Yuspeh RL, Huthwaite JS, et al. Healthy older adult performance on a modified version of the Cognistat (NCSE): demographic issues and preliminary normative data. J Clin Exp Neuropsychol. 2003;25(1):133-144.
137.
Knopman DS , DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9): 1143-1153.
138.
Brayne C., Fox C., Boustani M.Dementia screening in primary care: is it time? JAMA. 2007;298(20):2409-2411.
139.
U.S. Preventive Services Task Force.Screening for dementia: recommendations and rationale. Am J Nurs.2003;103(9):87, 89, 91, 93, 95.
Bossuyt PM , Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem. 2003;49(1):1-6.
142.
Reilly S., Challis D., Burns A., Hughes J.The use of assessment scales in old age psychiatry services in England and Northern Ireland. Aging Ment Health. 2004; 8(3):249-255.
143.
Shulman KI , Herrmann N., Brodaty H., et al. IPA survey of brief cognitive screening instruments. Int Psychogeriatr. 2006;18(2): 281-294.
